Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 6/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9640961 | 0.78 | PTGS1 (0.50) | PTGS1PTGS2MAPTKDM4EGAA | |
| SCHEMBL4097332 | 0.78 | NPC1 (0.48) | PTGS1PTGS2MAPTKDM4EGAA | |
| SCHEMBL4097331 | 0.78 | NPC1 (0.48) | PTGS1PTGS2MAPTKDM4EGAA | |
| SCHEMBL25420534 | 0.77 | PTGS1 (0.48) | PTGS1PTGS2MAPTKDM4EGAA | |
| SCHEMBL5541284 | 0.77 | PTGS1 (0.48) | PTGS1PTGS2MAPTKDM4EGAA | |
| SCHEMBL29804937 | 0.77 | PTGS1 (0.51) | PTGS1PTGS2MAPTKDM4EGAA | |
| SCHEMBL2568148 | 0.77 | PTGS1 (0.51) | PTGS1PTGS2MAPTKDM4EGAA | |
| SCHEMBL9640959 | 0.76 | PTGS1 (0.37) | PTGS1PTGS2MAPTKDM4EGAA | |
| SCHEMBL7523379 | 0.75 | MAOB (0.42) | MAPTKDM4ENPC1RAB9AMEN1 | |
| SCHEMBL7523377 | 0.75 | MAOB (0.42) | MAPTKDM4ENPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9812263-B2 | Compound and photoelectric conversion device | ADEKA CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-9812263-B2 | Compound and photoelectric conversion device | ADEKA CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-20160211085-A1 | NOVEL COMPOUND AND PHOTOELECTRIC CONVERSION DEVICE | ADEKA CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| US-9324889-B2 | Compound and photoelectric conversion device | ADEKA CORPORATION (JP) | 2016-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160211085-A1 | NOVEL COMPOUND AND PHOTOELECTRIC CONVERSION DEVICE | CYP1B1, PAH, CRY1 | PTGS1 2067/4885PTGS2 2680/4885MAPT 4548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.